U.S. Global Change Research Program Should Shift Focus to Preparing for and Avoiding Worst Potential Consequences of Climate Change, Says New Report (Includes Kris Ebi)

WASHINGTON — As it drafts its next decadal strategic plan, the U.S. Global Change Research Program (USGCRP) should shift its focus to providing insights that help society prepare for and avoid the worst potential consequences of climate change, while protecting the most vulnerable, says a new report from the National Academies of Sciences, Engineering, and Medicine.

COVID-19 In-Depth Report: Summary of Evidence Related to the Risk of Other Infections in the Context of COVID-19

Severe COVID-19 is associated with critical illness and immune dysregulation, both of which have been previously associated with increased risk of nosocomial infection. The care of COVID-19 patients has required dramatic changes to usual hospital practices and heightened concern for infection control practices. This is a brief summary of published evidence related to the effect of the COVID-19 pandemic on non-COVID infections.

Double Dose of Debate: Opinions Vary on Timing of COVID Vaccine Shots as Potential 4th Wave Looms (includes Ruanne Barnabas)

by Lisa Stiffler  / March 19, 2021

With COVID-19 vaccines still in limited supply and case counts threatening to resurge, there is a debate over the benefits of giving more people their first shot and waiting a longer time to administer the second dose, or whether to stay the course and prioritize getting both doses of the Pfizer and Moderna vaccine into arms as quickly as possible.

New COVID-19 In-Depth Report: Summary of SARS-CoV-2 Novel Variants

At just over one year into the COVID-19 pandemic, evolution of SARS-CoV-2 has generated viral variants that differ in their genetic sequence from the strain first detected in December 2019. Evidence is emerging about how these variants differ in their transmission characteristics, associated clinical symptoms, and vaccine efficacy. This document is a brief summary of published evidence about characteristics of SARS-CoV-2 variants that may impact the public health response, including transmission and response to vaccination.

United World Antiviral Research Network (UWARN) Partners Collaborate to Expand Understanding of New COVID Variants, Key to Future Vaccine Development

The recent recognition of new COVID-19 variants, first detected in South Africa (B.1.135, 501Y.V2), Brazil (P1) and the UK (B.1.1.7) – and the variants’ potential to disrupt vaccine effectiveness and protection from prior COVID-19 infection – is an urgent concern that UWARN partners around the globe are collaborating on to understand.

Pages